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Zoonotic viruses, such as HIV, Ebola virus, coronaviruses, influenza A viruses, hantaviruses, or he-
nipaviruses, can result in profound pathology in humans. In contrast, populations of the reservoir
hosts of zoonotic pathogens often appear to tolerate these infectionswith little evidence of disease.
Why are virusesmore dangerous in one species than another? Immunological studies investigating
quantitative and qualitative differences in the host-virus equilibrium in animal reservoirs will be key
to answering this question, informing new approaches for treating and preventing zoonotic dis-
eases. Integrating an understanding of host immune responses with epidemiological, ecological,
and evolutionary insights into viral emergence will shed light on mechanisms that minimize fitness
costs associated with viral infection, facilitate transmission to other hosts, and underlie the associ-
ation of specific reservoir hosts with multiple emerging viruses. Reservoir host studies provide a
rich opportunity for elucidating fundamental immunological processes and their underlying genetic
basis, in the context of distinct physiological and metabolic constraints that contribute to host
resistance and disease tolerance.Introduction
Emerging infectious diseases have an enormous impact on
human health (Marston et al., 2014). Viruses account for a signif-
icant proportion of emerging infections, and the majority have
zoonotic origins, including ebolaviruses, human immunodefi-
ciency virus (HIV), hantaviruses, Hendra and Nipah viruses,
severe acute respiratory syndrome (SARS) coronavirus, and
influenza A viruses (Jones et al., 2008; Taylor et al., 2001). Trans-
mission can occur directly to people from live reservoir hosts
(e.g., bat shedding of Nipah virus into date palm collection ves-
sels [Luby et al., 2006]). In other instances, exposures to novel
viruses have been associated with the butchering of reservoir
hosts, such as bush meat in SIV or simian foamy virus transmis-
sion (Hahn et al., 2000; Wolfe et al., 2004) and, recently, in the in-
dex case of the ebolavirus outbreak in the Democratic Republic
of Congo (WHO, 2014). Alternatively, transmission can be facili-
tated by intermediate hosts (e.g., Nipah virus infection of pigs in
Malaysia resulting in pig-to-pig and pig-to-human transmission
by aerosol [Parashar et al., 2000]) or can be transferred via insect
vectors, as is the case for Dengue fever and West Nile virus
(Mackenzie and Jeggo, 2013). Substantial growth in size and
mobility of human populations, along with environmental and
climate changes, and the spread of agricultural practices pro-
moting human-animal contact has led to an increased frequency20 Cell 160, January 15, 2015 ª2015 Elsevier Inc.of pathogen emergence and potential for rapid dissemination
(Karesh et al., 2012). Novel viruses are being described that
cause disease in humans, such as the recently identified Middle
East respiratory syndrome coronavirus (MERS-CoV) associated
with acute respiratory illness and renal failure (Zaki et al., 2012).
Other zoonotic viruses continue to spread into new populations,
as is the case for a current outbreak of Ebola virus in western Af-
rica, where this virus was not previously documented and where
it is having an unprecedented societal, economic, and public
health impact (Pandey et al., 2014; WHO Ebola Response
Team, 2014).
Tools to rapidly detect and sequence novel viruses have
greatly improved in recent years, facilitating their detection and
diagnosis in humans (Marston et al., 2014) and simplifying the
identification of putative reservoir hosts. For instance, the origins
of Ebola virus, although first identified in 1976, were only recently
tied to bats (Biek et al., 2006; Pigott et al., 2014). These tools are
enabling initiatives to monitor viruses in wildlife populations in
their natural habitat before they emerge in humans and other
animals (Mokili et al., 2012; Morse et al., 2012). Ecological,
epidemiological, and evolutionary processes involved in the
introduction and spread of pathogens in novel host populations
are the subject of intensive research (Antia et al., 2003; Holmes
and Drummond, 2007; Woolhouse et al., 2012). However, there
is little understanding of the within-host immunological pro-
cesses underlying reservoir host-virus interactions, and this
issue is rarely addressed in studies of emerging viral diseases.
Yet within-host processes are ultimately critical in determining
the outcome of infection, the balance between limiting infec-
tion-associated pathology and clearing the virus, and therefore
the likelihood of transmission.
Upon cross-species jumps, viruses can result in severe or fatal
disease in the novel, non-natural hosts, while these same viruses
often appear to cause onlymild infections in their reservoir hosts.
Examples exist in which circulating viruses can be lethal in reser-
voir host populations, as is the case for rabies virus in bat popu-
lations. But even rabies virus mortality rates were recently
estimated using epidemiological models as being much lower
in their natural bat reservoir (10%) than in other mammals
(Blackwood et al., 2013). As we will discuss, there have been
few detailed direct studies of the pathogenesis of emerging
viruses in their natural wildlife hosts, and given the notorious dif-
ficulty of measuring mortality rates in wildlife populations, some
reservoir host populations could be affected to a greater degree
than we currently understand. Longitudinal studies may reveal
fitness costs, even when the symptoms of infection are far less
pronounced than what is observed in non-natural human hosts.
One documented example is simian immunodeficiency virus in
chimpanzees (SIVcpz), the viral precursor of HIV-1 in humans.
SIVcpz leads to detectable depletion of CD4+ T cells and is asso-
ciated with shorter life spans and reduced reproductive success
of wild chimpanzees (Keele et al., 2009). Although SIVcpz infec-
tion is less pathogenic in chimpanzees than HIV-1 in humans, it
is not apathogenic. Whether this is related to the more recent
acquisition of SIV by chimpanzees as compared to the older
association of SIV with other African nonhuman primates is still
unclear (Bailes et al., 2003). In contrast, SIV infection of sooty
mangabeys and African green monkeys, two natural reservoir
hosts of SIV, despite a high prevalence in the wild and persistent
high-level viral replication, has no detectable impact on host
survival or health (Keele et al., 2009; Pandrea and Apetrei,
2010; Silvestri et al., 2003). In fact, in many cases, available
observations suggest that zoonotic viruses are able to persist in
natural reservoir populations for significant periods of time with
no overt signs of pathology.
Different viral zoonoses affecting humans are characterized by
distinct biological and clinical manifestations, with many of them
displaying a significant immunopathological component. Here,
we argue that elucidating the nature of immune responses in
individual natural hosts may inform our understanding of how
virus-host equilibria are established without substantially im-
pacting host health. Furthermore, this may provide insight into
the mechanisms of disease pathogenesis and immunity in hu-
mans. We ask whether there are fundamental immunologic
properties that govern different infection outcomes of natural
reservoir species compared to non-natural human hosts while
acknowledging that other aspects of host physiology, behavior,
or population biology may also play fundamentally important
roles. Further, we examine whether there are any immunological
principles underlying the association of specific reservoir host
species with multiple emerging viruses. Eventually, character-
izing the host-pathogen interface in key reservoir hosts mayenable us to predict which novel viruses are more likely to
pose threats to human health.
Pathogenesis of Emerging Viral Infections in Humans
The pathogenic mechanisms underlying disease manifestations
arising in humans infected with specific emerging viruses—
whether acute or chronic in nature—are diverse, complex, and
incompletely understood. Infection outcomes may vary from
resolving with only mild symptoms (e.g., simian foamy virus
[Wolfe et al., 2004]) to rapid developing severe disease that is
either fatal or cleared (e.g., ebolaviruses), whereas others are
persistent and lead to disease only after a prolonged period
(e.g., HIV). The balance between protective and pathogenic
immune responses is critical (Rouse and Sehrawat, 2010). A
pivotal role in this balance is played by innate immune effectors
that detect the presence of viral products by pattern recognition
receptors, thus initiating the host response (Iwasaki, 2012). The
specific cytokines, chemokines, and lipid mediators produced
in response to immune activation, as well as downstream adap-
tive responses that themselves can modulate the innate
response, can skew the relative balance between aggressive re-
sponses that rapidly clear infection and responses that minimize
the extent of immunopathology. Exuberant innate immune acti-
vation can also play a direct role in precipitating host organ tissue
damage (Cameron et al., 2008; Kuiken et al., 2012).
Despite a range of virus-specific mechanisms for pathogen-
esis, some common themes exist. In emerging viral infections
causing disease in humans in whom host responses have been
studied, innate immune responses are often thought to underlie
severe disease manifestations. In the acute respiratory infec-
tions with SARS CoV and influenza A, excessive innate immune
activation causes local tissue damage and compromises the
generation of protective adaptive immune responses (Kash
et al., 2006; Peiris et al., 2010). During infection with highly path-
ogenic influenza A viruses, production of inflammatory cytokines
and chemokines responsible for the recruitment of neutrophils
and mononuclear cells to the site of infection contributes to the
severity of the pulmonary disease and systemic complications
(Kuiken et al., 2012; Peiris et al., 2010). In addition, other media-
tors of inflammation, including sphingosine phosphates, also
play an important role in the immunopathogenesis of influenza
tissue damage and disease (Oldstone and Rosen, 2014). Spe-
cific virus strains such as H5N1 and the 1918 H1N1 viruses are
particularly potent in activating high-level sustained proinflam-
matory cytokine production following infection (Kash et al.,
2006; Peiris et al., 2010). Similarly, the pathogenesis of SARS in-
volves infection of important cell populations in the lung, along
with the elicitation of high levels of a range of inflammatory me-
diators (Totura and Baric, 2012). Importantly, in individuals who
resolve SARS CoV infections, evidence of active innate re-
sponses wane, and effective adaptive responses develop that
clear the infection. By contrast, individuals with poor outcomes
exhibit persistently elevated type I interferon (IFN) production,
IFN-stimulated gene (ISG) expression, and chemokine produc-
tion in association with impaired antiviral antibody responses
(Cameron et al., 2008; Totura and Baric, 2012).
For emerging viruses that cause hemorrhagic fever, dysregula-
tion of the host response, the induction of inflammatoryCell 160, January 15, 2015 ª2015 Elsevier Inc. 21
mediators, and the impairment of adaptive immunity, in addition
to direct viral damage of host tissues, are central to pathogenesis
(Geisbert and Jahrling, 2004). In fatal human filovirus infections
(of which Ebola virus is the best studied), antigen-presenting
cells, including dendritic cells and macrophages, represent
important targets for virus infection in vivo. High levels of proin-
flammatory cytokines, chemokines, and tissue factor lead to
lymphocyte apoptosis, pathologic activation of coagulation cas-
cades, and widespread compromise of vascular integrity that
results in multiorgan failure and a septic shock-like syndrome
(Martinez et al., 2012; Misasi and Sullivan, 2014; Zampieri et al.,
2007). In infections (for instance,withWestNile virus) inwhich en-
cephalitis due to viral penetration of the blood-brain barrier leads
to neuropathology, inflammatory responses may be responsible
for blood-brain barrier compromise (Wang et al., 2004).
In HIV infection, a persistent yet ineffective host response in
the face of chronic viral replication contributes substantially to
pathogenesis. Erosion of immunocompetence was initially
thought to arise from active virus replication causing progressive
depletion of CD4+ T cell populations. However, more recent ev-
idence indicates that chronic, pleiotropic immune activation (evi-
denced by increased activation, proliferation, apoptosis, and
dysfunction across diverse immune effector cell populations)
during HIV infection is the major driver of progressive immune
deficiency leading to AIDS (Moir et al., 2011). A key contributor
to chronic immune activation in HIV is the ability of unrelenting vi-
rus replication to stimulate host innate immune responses and
the production of type I IFNs and other proinflammatory cyto-
kines (Miedema et al., 2013). The resulting compromised infec-
tion resistance may further amplify systemic immune activation
and exacerbate its damaging effects by resulting in the expan-
sion of the enteric virome, damaging the intestinal epithelium
and leading to the translocation of intestinal bacteria, viruses,
and the antigens derived from them (Brenchley et al., 2006; Han-
dley et al., 2012).
Of note, in many instances, viral proteins produced by
emerging viruses antagonize specific immune recognitionmech-
anisms or circumvent cell-intrinsic restriction factors, thereby
influencing host antiviral responses and viral replication kinetics.
Given the central role of type I IFN in the direct inhibition of viral
replication within cells and in the activation and execution of host
innate and adaptive immune responses, it is not surprising that
diverse viral gene products have been shown to specifically
block the induction or the effects of the host IFN response. Ebo-
lavirus VP35 and VP24, lassa virus NP, influenza virus NS1,
SARS CoV NSP1, and ORF3b are just a few examples (Ayllon
and Garcia-Sastre, 2015; Hastie et al., 2012; Totura and Baric,
2012). Viral products have also been demonstrated to intercept
ISGs, other immune recognition pathways, restriction factors,
or production of effector molecules (Menachery et al., 2014).
Features of the virion, such as the complex structure and heavy
glycosylation of the HIV-1 envelope protein gp120, can make
them less effective targets for elicitation of neutralizing antibody
responses or structurally impervious to them when they arise
(Burton et al., 2005). Moreover, the viral genome itself plays a
role in the rapid evasion of adaptive immune responses, with
the generation of diverse viral quasispecies that is an inherent
consequence of error-prone RNA replication mechanisms22 Cell 160, January 15, 2015 ª2015 Elsevier Inc.(Holmes and Drummond, 2007). Thus, the efficacy of the host
response to infection depends on the complex interplay of bene-
ficial activation of innate and adaptive immune responses, the
potency and impact of viral strategies for immune evasion, and
the deleterious consequences of protracted or misdirected im-
mune responses.
Reservoir Host Infection and Disease Tolerance
A number of nonmutually exclusive hypotheses might explain
why many reservoir hosts of viruses capable of causing disease
in humans or other animal hosts do not show severe clinical or
behavioral signs of infection (Table 1): (1) the virus is cytopathic
in the nonnatural host, but not in its reservoir, (2) viral tropism dif-
fers between natural and non-natural hosts, (3) differences in the
interaction between the viral genome or viral gene products and
host resistance mechanisms alter the infection outcome be-
tween natural and non-natural hosts, (4) the virus confers a
benefit to the host that is not conferred to humans or other animal
host species, (5) interactions within the zoonotic host between
the virus and other elements of the microbiome alter the patho-
genesis of infection in a manner that does not apply to humans,
(6) reservoir host responses control viral replication more effec-
tively, or (7) viral infection is better tolerated by reservoir hosts
even when viral loads are high. In most cases, knowledge about
the features of viral infections in their reservoir hosts and immune
responses elicited is incomplete, and it remains unclear which of
these explanations holds for particular zoonotic viruses (Table 1).
Moreover, as-yet-undiscovered mechanisms may exist which
the study of reservoir hosts could reveal.
In some cases, differences in viral tropism may influence the
host-virus interface, resulting in reduced pathogenesis. For
instance, in the sooty mangabey, a natural host for the SIV that
is the origin of HIV-2, long-lived memory T cells may be more
resistant to infection due to reduced CCR5 expression (a core-
ceptor for SIV) such that T cell homeostasis is preserved (Paiar-
dini et al., 2011). Similarly, memory CD4+ T cells in African green
monkeys downmodulate CD4 expression, rendering them resis-
tant to SIV infection and to infection-induced dysregulation of
their homeostasis (Beaumier et al., 2009).
Alternatively, the role of viral genetic functions and structural
attributes in shaping the nature and consequences of host-vi-
rus interactions may be distinct in natural versus non-natural
hosts. Interestingly, most studies thus far have used non-natu-
ral hosts or their cells to explore the interaction of viral products
with host resistance mechanisms and impact on viral virulence.
In fact, much of our current understanding of viral immune
evasion and restriction factor inhibition strategies has come
from studies of emerging viruses. However, although these
strategies can be fit in a logical framework in the context of a
pathogenic infection, it is not clear how such regulatory and
structural mechanisms function or evolved within a nonpatho-
genic reservoir host environment, whether they promote virus
persistence or limit pathologic consequences of infection, and
how they impact cross-species jumps. For example, the type
I IFN-inducible host cell restriction factor tetherin, identified
as a cellular factor that acts to restrict the release of newly pro-
duced HIV-1 particles from the surface of human cells, is
antagonized by the HIV-1 accessory protein Vpu. Of the four
Table 1. Features of Emerging Viruses in the Natural Reservoir Hosts from which They Originated
Virusa (Family) Genome Pathogenesis in Humans Natural Host
Features of Infection and Immune Response in Natural Host
Virus Replication Innate Response Ab/B Cell T Cell Treg
Bas-Congo (Rhabdoviridae) ssRNA acute hemorrhagic fever ? ? ? ? ? ?
MERS Coronavirus
(Coronaviridae)
+ssRNA acute pneumonia, renal failure bats, camels ? ? ? ? ?
Chikungunya (Togaviridae) +ssRNA high fever, skin rash, arthralgia African primates ? ? ? ? ?
Crimean-Congo hemorrhagic
fever (Bunyaviridae)
ssRNA hemorrhagic fever hares, large herbivores? ? ? + ? ?
Ebola (Filoviridae) ssRNA hemorrhagic fever fruit bats ? ? + ? ?
Hanta (Bunyaviridae) ssRNA hemorrhagic fever with renal
syndrome, cardiopulmonary
syndrome
rodents, shrews,
and bats
P anti-inflamm tory + (+) +
Hendra and Nipah
(Paramyxoviridae)
ssRNA severe acute encephalitis,
respiratory disease, systemic
vasculitis
fruit bats ? ? + T/P ? ?
Hepatitis E (Hepeviridae) +ssRNA hepatitis pigs ? ? ? ? ?
HIV (Retroviridae) ssRNA AIDS African primates P (high) diminished ronic
type I IFN
(+) (low titres) (+) +
Influenza A
(Orthomyxoviridae)
ssRNA respiratory disease aquatic birds T? variations in nate
signaling pa ways
+ ? ?
bats?
Lassa (Arenaviridae) ssRNA mild febrile illness but can result in
hemorrhagic fever
rodents P ? + ? ?
Lymphocytic
choriomeningitis
(Arenaviridae)
ssRNA mild febrile illness to meningeal
symptoms; fatal in
immunocompromised
rodentsb P, T? ? + ? ?
Menangle (Paramyxoviridae) ssRNA influenza-like illness and rash fruit bats ? ? + ? ?
SARS coronavirus
(Coronaviridae)
+ssRNA progressive atypical pneumonia horseshoe bats ? ? + ? ?
Rabies (Rhabdoviridae) ssRNA neurological disease bats T? ? + T? ? ?
Rift Valley fever (Bunyaviridae) ssRNA hemorrhagic fever ? ? ? ? ? ?
West Nile (Flaviviridae) +ssRNA fever, meningoencephalitis birds? ? ? + ? ?
Yellow fever (Flaviviridae) +ssRNA hemorrhagic fever, jaundice African primates T ? + ? ?
T, transient; P, persistent; ?, unknown;+, present; –, undetectable; (+), present but weak/low compared to non-natural hosts.
aThe list is not exhaustive but highlights representative examples of emerging viral infections. See also Table S1 for a complete list of references.
bNote that, although LCMV infection of inbred laboratory mice is an extremely well-studied pathogen-host system and a lot is known about the immuno gical responses during chronic and acute
LCMV infections, very little is known about LCMV infection in wild rodents, circulating strains, whether virus is cleared or persistent, and how much th depends on the rodent species and virus
strain in question.
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groups of HIV-1 (M, N, O, and P) that arose via independent
transmission events from chimpanzees, only group M viruses
have become pandemic—the group shown to possess the
most potent anti-tetherin activities (Sauter, 2014). Tetherin
also inhibits the egress of arenavirus, filovirus, and rhabdovirus
particles from infected cells, and proteins such as Ebola virus
GP1,2 counteract the effects of tetherin (Misasi and Sullivan,
2014; Sauter, 2014). But whether these have a similar role in
their reservoir hosts remains to be examined.
Innate and adaptive immune cell development and their acti-
vation thresholds are calibrated by interactions with commen-
sals or previous pathogen encounters. Thus, it is possible that
the overall microbial environment of a reservoir host species
contributes to altering the outcome of a viral infection. For
example, helminth infection can either reactivate herpesviruses
from latency through generation of cytokines that activate or
repress viral promoters (Reese et al., 2014), or it can directly
inhibit T cell responses (Osborne et al., 2014). Multiple studies
now indicate that the microbiome alters host responses to viral
and parasite infection (Virgin, 2014). In some cases, these pro-
longed relationships may confer a mutualistic symbiotic advan-
tage to the host species (Barton et al., 2007). Thus, a reservoir
host may tolerate a given chronic infection and offset any fitness
cost of this infection by the benefit of altered host resistance to
other pathogens. However, there are as yet few studies that
explore this set of issues that might distinguish the outcome of
infection between a natural host and humans (Virgin, 2014; Virgin
et al., 2009).
Lastly, an important set of mechanisms that determine the
capacity of a reservoir host to carry a dangerous virus may be
the host’s ability to tolerate the damage caused by a specific
pathogen or by the immune responses raised to it. This param-
eter, termed disease or infection tolerance, is measured as the
rate of change in disease severity as a function of pathogen
loads and is in contrast to host resistance mechanisms, which
reduce pathogen burden (Schneider and Ayres, 2008). Interest-
ingly, evolutionary theory predicts that, because pathogens will
engage in an arms race with the host to evade resistance mech-
anisms but there is no selection on pathogens to evade disease
tolerance mechanisms, resistance traits will be more polymor-
phic in a population than tolerance traits (Roy and Kirchner,
2000). We note that immune tolerance as defined by diminished
immune responses to a given antigen is only one component of
disease tolerance. The concept of disease tolerance was first
examined in the context of selective pressures exerted by par-
asites and herbivores on plant evolution, and it is only recently
that studies have begun to examine disease tolerance in
mammalian host-parasite interactions (Ra˚berg et al., 2007; Re-
goes et al., 2014) and investigate the pathways involved (Fig-
ueiredo et al., 2013; Jamieson et al., 2013; Jeney et al., 2014;
Rodrigue-Gervais et al., 2014; Weber et al., 2014). Character-
izing disease tolerance mechanisms is of particular importance
to understanding the absence of severe disease in reservoir
hosts and in the development of methods able to modulate
the human response to the same virus without the risk of select-
ing for viral evasion mechanisms. An immunologic understand-
ing of reservoir host species biology will include the study of all
mechanisms by which the host species minimizes the overall24 Cell 160, January 15, 2015 ª2015 Elsevier Inc.fitness costs to the individual or the population, attendant on
carrying a given pathogen in a form that is transmissible to hu-
mans.
Disease Tolerance and Transmission of Zoonotic
Viruses
Determining the kinetics of viral replication, the extent of im-
mune control, and parameters that might impact these, such
as genetic variation, hibernation, pregnancy, or stress, may
provide key insights into why some viruses are more likely to
make cross-species jumps and why some of these cause
severe disease in humans. Indeed, for many reservoir hosts,
immune responses have not been characterized beyond
demonstrating seroconversion (Table 1). Further, population-
level persistence of emerging pathogens in their reservoirs
has primarily been investigated from an ecological perspective,
and the contribution of the host response to determining pop-
ulation-level infection dynamics within reservoirs is unclear.
Experimental studies will provide critical data to improve field
ecological studies by identifying which age classes, gender,
or status of individual to focus on in studying transmission
events. Experimental infections will also form the basis for
improving dynamic modeling of infectious diseases, which is
used to assess infection risk and develop better controls to
prevent spillovers (Lloyd-Smith et al., 2009). A substantial list
of important biological questions remains to be answered
through focused experimental studies of the interfaces be-
tween various reservoir hosts and the specific viruses they
harbor (Box 1).
The extent to which immune responses limit viral replication
in reservoir hosts is likely an important factor in the probability
of cross-species transmission. Chronic or repeated virus
shedding in infected reservoirs increases the likelihood of
transmission due to the greater number of virus particles in
the inoculum for each exposed individual. In addition, immuno-
logical effector mechanisms that substantially restrict virus
replication will affect viral genetic diversity and evolution in
ways that may impact the spillover probability and the strain
structure present in the reservoir host population (Box 1). A
greater viral diversity may increase the chances that at
least a few viral variants are able to successfully establish an
infection in the novel host. Thus, we speculate that viruses
that have either chronically high virus levels or repeated tran-
sient high pathogen burdens in their natural hosts may be
overrepresented among emerging viral pathogens in humans
(Figure 1).
Interestingly, experimental data has suggested that, in the
case of malaria infection, increased tolerance may come at
the cost of reduced resistance (Ra˚berg et al., 2007). Such a
tradeoff arises if resistance and tolerance are mechanistically
connected. For instance, more aggressive effector responses
that result in superior pathogen replication control may also
be the responses that lead to increased collateral damage.
Alternatively, such a tradeoff might be observed if resistance
and tolerance are energetically costly, and it is only feasible
to invest resources in one of the two strategies. Moreover,
attenuated immune responses may result in waning immuno-
logic memory. For instance, anti-yellow fever virus (YFV) anti-
body titers following YFV vaccination declined far more rapidly
Box 1. A Checklist for Studying Emerging Viruses in Reservoir Hostspost infection in sooty mangabeys, a primate reservoir for YFV,
than in YFV-disease susceptible rhesus macaques and humans
(Mandl et al., 2011). Whether a tradeoff between resistance and
tolerance is a generalized phenomenon remains to be investi-gated. A study of the rate of decline in CD4+ T cells across
different HIV viral load set points in humans found no relation-
ship between resistance and tolerance, although it may be the
case that such a link would only become apparent over aCell 160, January 15, 2015 ª2015 Elsevier Inc. 25
Figure 1. Reservoir Host Infection and Dis-
ease Tolerance
A feature of zoonotic infections in an individual
natural hostmay be the tolerance of high pathogen
burdens in the absence of substantial deviation
from health. Phase plots (adapted from Schneider
and Ayres [2008]) illustrating possible infection
trajectories following infection to highlight differ-
ences between novel and reservoir hosts in the
extent of viral replication, viral kinetics, and asso-
ciated disease burden. Transmission of zoonotic
viruses may be more likely in cases in which there
are persistently high viral loads or repeated acute
infections of reservoir hosts. Within a population of
the reservoir host, repeated infections with a
pathogen may occur as a result of waning immu-
nological memory within individuals, circulation of
diverse strains to which there is minimal cross-
reactive immunity, or the introduction of new
susceptible individuals (juveniles). To what extent
and in which instances features of the immune
response in reservoir hosts contribute to pathogen
maintenance in a population is an important open
question.longer period of host-pathogen coevolution (Regoes et al.,
2014).
Several examples have been described in which zoonotic vi-
ruses replicate at persistently high levels in their reservoirs. SIV
establishes chronic infections in African primate species with
high levels of viremia and little evidence of effective immune
control (Pandrea and Apetrei, 2010; Silvestri et al., 2003).
Hantavirus infections of rodent reservoirs result in persistence
even in the presence of high antibody titers (Easterbrook and
Klein, 2008; Schountz and Prescott, 2014). For both of these
viruses, extensive within-host and between-host viral diversity
has also been described in their natural hosts, and distinct
strains are associated with distinct host species, suggestive
of a coevolutionary history (Demma et al., 2005; Feuer et al.,
1999).
In contrast, infections of wild waterfowl (Anas platyrhynchos)
with influenza A virus were shown to be transient (Jourdain
et al., 2010). Given the high prevalence of seropositivity and
the presence of an enormous diversity of influenza A strains pre-
sent in birds (Verhagen et al., 2012), this might be an example in
which reservoir hosts previously infected with one strain are only
partially protected from infection with co-circulating viral strains,
but this requires further investigation. In pteropid fruit bat spe-
cies, infections with Hendra and Nipah viruses are likely also
transient, but few experimental infection studies have been
done so far and the infection incidence is currently unknown
(Halpin et al., 2011; Middleton et al., 2007). These viruses have
been detected at a prevalence of around 1% or less, although
seroprevalence can be as high as 60% (Breed et al., 2013; Rah-
man et al., 2013). Given the seasonal and synchronous breeding
of these bats, it is difficult to distinguish whether there are sea-
sonal increases in incidence due to infections of susceptible ju-
veniles whose maternal antibodies have waned (Epstein et al.,
2013), or changes in bat immunity that enable reinfections or
the reactivation of low-level infections (Sohayati et al., 2011).
Clinical manifestations of infection, such as sneezing, cough-
ing, or diarrhea, can facilitate transmission between humans26 Cell 160, January 15, 2015 ª2015 Elsevier Inc.for certain zoonotic viruses where between-human secondary
transmissions occur (Wolfe et al., 2007). SARS-CoV, for
example, is transmitted by aerosolization and droplet infection
between humans (Peiris et al., 2004), and Ebola virus spreads
via contact with blood or body fluids (Dowell et al., 1999). In
the absence of symptoms in disease-tolerant reservoir hosts,
the routes of viral infection may be distinct from those observed
in non-natural hosts. Whereas Nipah and Hendra virus is primar-
ily respiratory in horses and pigs, transmitting oro-nasally (Geis-
bert et al., 2012), in bats, these viruses are shed in saliva and
urine and may also be transmitted vertically (Halpin et al.,
2000). For most zoonotic viruses, the transmission mode be-
tween reservoir hosts remains unknown.
Mechanisms of Disease Tolerance and Innate Immunity
Studying immune responses of reservoir hosts to their viruses
provides a unique opportunity to define molecular mechanisms
underlying disease tolerance and to identify therapeutic targets
to prevent the dysregulated immunopathology that often charac-
terizes infections of novel hosts. Mechanisms of disease toler-
ance (Schneider and Ayres, 2008) must have some degree of
pathogen specificity tomaintain immunocompetence. Innate im-
munity and mechanisms of recognizing viral invasion of cells are
an important first line of host defense, and signals downstream
of innate immune receptors play a key role in the magnitude of
the immune response initiated (Iwasaki, 2012). Viruses can
trigger endosomal, cell surface, or cytosolic innate immune
receptors in a nucleic-acid-dependent manner (by their whole-
genome, replication products or intermediates) or in a nucleic-
acid-independent manner by virion glycoproteins or by more
general changes associated with cellular stress (Iwasaki,
2012). It follows that investigating the innate immune recognition
of zoonotic viruses in their reservoir hosts will provide impor-
tant insight into how pathogen-specific disease tolerance is
achieved.
Though innate recognition mechanisms are evolutionarily
conserved, their complexity is becoming increasingly apparent.
Regulatory factors are being identified that contribute to
Figure 2. Differences in Immune Responses of Reservoir Hosts Impact Disease Tolerance, Infection Outcome, and the Probability of
Emergence in Humans
Qualitative or quantitative aspects of innate or adaptive immune responses and their cross-talk may differ in reservoir hosts compared to novel hosts, impacting
viral replication kinetics, decreasing pathology, and/or increasing the likelihood of transmission. Thus, reservoir host antiviral immunity may be one factor im-
pacting the probability of emergence of a zoonotic virus in humans, in addition to other ecological, evolutionary, or virological risk factors.amplifying or dampening signaling pathways downstream of
innate receptors and impact the type and amount of cytokines
produced (Qian and Cao, 2013). In addition, the existence of ge-
netic heterogeneity within and between populations is emerging
as an important factor contributing to host variation in innate im-
mune responses to infection and susceptibility to disease (Lee
et al., 2014; Pothlichet and Quintana-Murci, 2013). In contrast,
an understanding of variation in quantitative parameters, such
as measures of maximum response, half-maximal effective con-
centration, the dose of stimuli at which a response is initiated, the
kinetics of the response, and the total magnitude of the response
(by measures such as area under the curve), is still lagging
behind, even in humans and mice, and may well turn out to be
a critical aspect in explaining differences between hosts. Ulti-
mately, heterogeneity in qualitative and quantitative aspects of
an immune response and the selection pressure exerted by spe-
cific pathogens shapes the innate immune system of a species
and thus impacts responses to future encounters with novel in-
fectious agents (Barreiro and Quintana-Murci, 2010), as well as
perhaps baseline cellular states (for which the relevant measures
are not always clear). Yet, species-specific differences in re-
sponses to immune stimuli are only beginning to be described
(Barreiro et al., 2010; Brinkworth et al., 2012; Seok et al., 2013).In reservoir hosts, specific changes in innate immune recogni-
tion, innate signaling pathways, cross-talk with the adaptive im-
mune system, or the generation and differentiation of B and
T cells may play a key role in the disease tolerance to viruses
that they harbor (Figure 2). Understanding which receptors,
modulating factors, or deleterious molecular mediators are
involved will allow us to target these in humans to alter infection
outcome. For instance, blocking specific immune signaling path-
ways during pathogenic ebolavirus or henipavirus infection
through which signaling is reduced in bat reservoir hosts upon
infection may reduce tissue damage in humans. Alternatively, in-
hibiting specific ISGs found to be activated in non-natural hosts
but that are quiescent in natural hosts may reduce downstream
detrimental proinflammatory effects in infections such as HIV
without preventing the antiviral effects of other ISGs induced,
rather than blocking type I IFN completely (Sandler et al., 2014;
Schoggins et al., 2011).
Innate immune responses can play a directly beneficial role in
effecting early viral control following infection and are of funda-
mental importance in generating adaptive cellular and humoral
immune responses required to limit virus replication. Thus, the
absence of RIG-I, a sensor of viral RNA ligands, has been hy-
pothesized to make chickens less resistant to influenza virusesCell 160, January 15, 2015 ª2015 Elsevier Inc. 27
as compared to natural bird reservoirs such as ducks (Barber
et al., 2010). However, specific innate immune responses may
also precipitate immunopathologic consequences. For example,
the absence of TLR3 leads to a reduced production of inflamma-
tory mediators and improved survival upon infection with phle-
bovirus or influenza A viruses, despite similar or increased levels
of viral replication (Gowen et al., 2006; Le Goffic et al., 2006). IL-
17RA knockout mice infected with influenza A virus also display
lower expression of inflammatory cytokines and chemokines,
reduced lung inflammation, and improved survival despite hav-
ing higher levels of virus replication as compared to wild-type
laboratory inbred mice (Peiris et al., 2010). In addition, studies
of different inbred mouse strains that are either susceptible or
resistant to influenza-associated mortality have demonstrated
greater activation of genes associated with inflammatory re-
sponses in susceptible mice and have begun to define the un-
derlying genetic determinants of divergent infection outcomes
(Peiris et al., 2010). Importantly, differences in responses be-
tween natural and non-natural hosts may not simply be due to
the presence or absence of specific receptors or the switching
on or off of specific signaling cascades. Rather, in the context
of complex immune processes and cellular interactions, even
small differences in the magnitude or timing of responses can
substantially alter infection outcome. The use of mathematical
models and careful measurements of rates of change of key
response parametersmay be required to ensure that such expla-
nations are not missed.
Currently, the best-studied reservoir host responses are those
of African primate species to SIV and of rodent species to hanta-
virus (Easterbrook and Klein, 2008; Miedema et al., 2013;
Pandrea andApetrei, 2010; Schountz andPrescott, 2014). Unlike
humans infected with HIV, African primates do not develop the
severe immune dysfunction and susceptibility to opportunistic
infections that characterize AIDS. Pathogenic lentivirus infec-
tions in non-natural human or rhesus macaque hosts are associ-
ated with an elevated expression of ISGs and increased levels of
immune activation, which includes increases in the activation
and proliferation of T cells (Moir et al., 2011). During HIV infection,
the majority of type I IFN production is likely due to the recogni-
tion of HIV by TLR7 expressed by pDCs (Beignon et al., 2005).
However, in marked contrast to pathogenic HIV and SIV infec-
tions, an ISG expression signature is absent in sooty mangabeys
during chronic SIV infection (Mandl et al., 2008). Further, chron-
ically SIV-infected sooty mangabeys do not display elevations in
aberrant T cell activation and its consequences (Silvestri et al.,
2003). Whether the absence of chronic type I IFN production in
sooty mangabeys is a result of reduced pDC activation by SIV
or a function of actively suppressive mechanisms remains
debated (Bosinger et al., 2013; Mandl et al., 2008). In African
green monkeys, another reservoir host for SIV, a similar absence
of an ISG expression signature during chronic SIV infection has
been described (Jacquelin et al., 2009). In addition, SIV infection
of African green monkeys is associated with an anti-inflamma-
tory gene expression signature (Kornfeld et al., 2005). Interest-
ingly, baseline cellular activation states, as measured by Ki67
on NK and T cells, are significantly lower in sooty mangabeys
and African green monkey reservoir hosts than in the non-natu-
ral, AIDS-susceptible rhesus macaque host, though the rele-28 Cell 160, January 15, 2015 ª2015 Elsevier Inc.vance of this for immune response parameters upon infection
has not yet been explored (Mandl et al., 2008).
The situation in hantavirus-infected rodents has some notable
parallels to host-virus interactions in SIV-infected primates.
Rodents infected with hantavirus do not show signs of disease
or of discernable fitness costs (Easterbrook and Klein, 2008;
Schountz and Prescott, 2014). As in SIV-infected AGMs, induc-
tion of regulatory T cells at later stages of hantavirus infection,
while resulting in viral persistence, reduces effector T cell re-
sponses and is thought to limit immunopathology (Table 1) (East-
erbrook and Klein, 2008; Schountz and Prescott, 2014. Exactly
how the switch from initial immune activation to a dampened
response is mediated in rodents infected with hantavirus is still
unclear. Specific viral proteins may interact with rodent immune
pathways to limit proinflammatory responses while at the same
time preventing clearance. Alternatively, or in addition, as may
be the case for African primates infected with SIV, changes in
innate recognition could directly lead to reduced pathology
due to the reduction in the production of inflammatory mediators
or due to the induction of responses that actively suppress
damaging responses. Adaptive immune responses may also
play a major role in modulating innate immunity in reservoir
hosts. For example, cytokines secreted by activated T cells
can activate or suppress innate cells, and antigen-antibody
complexes impact innate cell function via Fc receptor signaling.
The induction of inhibitory receptors on T cells, such as PD-1,
can directly contribute to limiting T-cell-mediated pathology
while preventing viral clearance (Barber et al., 2006; Frebel
et al., 2012) (Figure 2). Recent data from chronically lymphocytic
choriomeningitis virus (LCMV)-infectedmice has highlighted that
an expanded population of regulatory T cells dampens CD8+
T cell responses and that the depletion of regulatory T cells in
conjunction with the blockade of PD-1 signaling substantially re-
duces viral load (Penaloza-MacMaster et al., 2014).
The innate sensors of nucleic acid engaged by a specific virus
are a function of its genome. Therefore, the innate pathways
important to sensing viruses with the same genomic composi-
tion or replication scheme often overlap substantially (Iwasaki,
2012). It has been hypothesized that viruses sharing cell tropism
and features that result in their recognition by the same innate re-
ceptor, termed ‘‘virotypes,’’ will trigger the same host transcrip-
tional response (Virgin, 2014). As a consequence of this, it is
possible that changes in a discrete innate pathway predispose
certain reservoir hosts to asymptomatically harbor multiple vi-
ruses recognized by the same pathway if such changes increase
disease tolerance to these virotypes in similar ways. Data from
human studies have shown that deficiencies—in particular,
innate receptor signaling molecules—can result in very defined
and narrow susceptibilities to only a few specific pathogens
(Al-Herz et al., 2014). Redundancies in immune recognition
explain why reservoir host-pathogen associations might be
very specific and thus not impair resistance to other pathogens.
Sooty mangabeys, in addition to being reservoirs for SIV, are
also natural hosts for yellow fever virus (YFV) and remain disease
free upon infection. Studies of immune responses of sooty man-
gabeys to YFV have shown that, like for SIV, they mount reduced
effector T cell responses following YFV infection compared to
humans and macaques (Mandl et al., 2011). Both YFV and SIV
stimulate type I IFN upon recognition by TLR7, so this raises the
intriguing possibility that specific changes in TLR7 signaling in
sooty mangabeys impact their adaptive immune responses to
these viruses.
Indeed, patterns of reservoir host and viral associations have
been observed, but their biological significance is unclear, given
the only very recent increase in comprehensive studies of spe-
cies’ viromes. For instance, bats are the reservoir of several
emerging infectious agents, the majority of which are single-
stranded RNA viruses, such as SARS coronavirus, MERS
coronavirus, Nipah and Hendra viruses, rabies, and related lys-
saviruses Menangle virus, Marburg, and Ebola viruses (Table
1). Bats may also be the ancient natural host reservoirs of the fla-
vivirus hepatitis C (Quan et al., 2013). Is this merely a result of
biases in sampling and analysis, or does the coevolution of a
host with one virus of a given virotype open awindow to infection
with others of the same virotype? Is this a result of life history
traits of bats and/or a function of species-specific variations in
innate immune recognition of RNA viruses between humans
and bats? Some studies have suggested that bats are dispro-
portionately responsible for viral emergence relative to species
diversity, but this conclusion and the reasons for the association
of bats with zoonotic viruses remain a matter of debate (Luis
et al., 2013; Olival et al., 2013). Interestingly, many viruses that
cause persistent infections in humans use DNA as genomic
material (Virgin et al., 2009). Is this entirely a property of these
viruses or a result of a coevolution of our immune response
with DNA virotypes that is different in other mammalian species
with a distinct history of virus encounters? Zoonotic DNA viruses
that cause disease in humans certainly exist, including monkey-
pox and herpes B viruses. A comparative and immune-centric
understanding of virus-host relationships between virotypes
and species will be required to investigate such questions. As
our data set on host-virus associations increases, so will our
ability to discern patterns and investigate their causes.
Reservoir Host Physiology, Metabolism, and Infection
Tolerance
Studying reservoir host responses will enable us to more accu-
rately measure the true physiological impact of emerging viruses
on their coevolved host. The immune system is embedded in
the complex physiology of an organism, and as such, infections
and the immune responses that they elicit trigger behavioral,
autonomic, endocrine, and metabolic effects. Soluble immune
mediators like IL-1 and TNFa result in ‘‘sickness behavior,’’
such as social withdrawal and decreases in food intake and mo-
tor activity in infected individuals (Dantzer et al., 2008). Specific
changes in metabolism during inflammation can lead to
cachexia, which is particularly well documented in Mycobacte-
rium tuberculosis (once termed ‘‘consumption’’), or HIV (once
termed ‘‘slim disease’’) infections or to local changes in tissue
microenvironment. In turn, metabolic processes and changes
in body temperature can impact host immunity. Metabolic by-
products can recruit immune cells to sites of infection, activate
innate immune cells via recognition through the pattern recogni-
tion receptors, which also sense microbial products, and initiate
the resolution of inflammation (Jin et al., 2013; Kominsky et al.,
2010). Nutrients, metabolites, and oxygen availability within tis-
sues can impact immune cell effector functions and immune ho-meostasis (Pearce and Pearce, 2013; Sitkovsky and Lukashev,
2005).
It is possible that fundamental differences in reservoir host
physiology and the circuitry that interfaces with the immune sys-
tem are the consequence of distinct evolutionary tradeoffs be-
tween species and impact infection outcome or the resulting
disease manifestations. For instance, bats have evolved unique
life history traits that may have influenced their exposure to and
interaction with pathogens in ways that have led to distinct virus-
host de´tentes. Bats are capable of sustained flight and have
exceptionally long lifespans despite their high metabolic rates
and small body size (Wilkinson and South, 2002). Consistent
with the idea that changes in energy metabolism were required
to meet the extraordinary cost of flight, mitochondrial and nu-
clear genes involved in oxidative phosphorylation have under-
gone positive selection in bat lineages (Shen et al., 2010).
Concomitant selection pressure on DNA damage repair pathway
genes to prevent negative physiological effects of highmetabolic
rates caused by the release of reactive oxygen speciesmay have
had as yet undefined consequences for innate immune re-
sponses to viruses (Zhang et al., 2013). Hibernation has also
been associated with altered immune cell function and reduced
lymphocyte trafficking, an understanding of which could be key
to explaining the devastating impact of White-nose syndrome in
North American bat populations (Bouma et al., 2010; Meteyer
et al., 2012).
An Experimental Toolkit for Reservoir Host Immunology
Detailed assessments of immune responses in reservoir host
species have been challenging for a number of reasons. One
practical constraint has been establishing colonies of reservoir
host species to enable longitudinal experiments under controlled
conditions. Immunological field studies, though valuable in spe-
cific instances, can be difficult to interpret given that pathogen
exposure status between sampling time points is unknown and
it may not always be possible to recapture the same individuals.
However, keeping reservoir host colonies can require specific
animal husbandry techniques, may involve training animals to
accept available food sources not eaten in the wild, and can
require access to special facilities to maintain the animals
(such as aviaries to harbor bats or birds) and to perform infec-
tions with viruses that are often lethal to humans. Moreover, im-
porting reservoir hosts from their country of origin can be costly,
and quarantines are required to ascertain that they are free of the
zoonotic pathogens dangerous to humans. The lack of experi-
mental studies of wildlife reservoirs is also a product of our
poor understanding of the true wildlife reservoirs for a number
of recently emerged viruses. However, such studies, if conduct-
ed correctly, are critical to understanding pathogenesis and the
risk of exposure for humans.
A second technical challenge to studies of reservoir host im-
munity has been the establishment of viral infection models
that mimic infection in the wild and that are useful for investi-
gating pathogen kinetics and immune responses over time in a
setting where the time of infection is known and other environ-
mental parameters can be controlled (Box 1). Extensive viral
passaging in vitro, especially in cells lines that, while permissive
for infection, may be quite distinct from cells infected in vivo, canCell 160, January 15, 2015 ª2015 Elsevier Inc. 29
lead to the selection of viral variants that can no longer replicate
effectively in the host of origin. Similarly, the use of clonal viruses
can be problematic in recapitulating typical outcomes of natural
infections should initiation of infection with diverse viral quasis-
pecies be important. As such, the choice of viral inoculum can
greatly influence the course of infection. For example, in studies
of sooty mangabeys in which highly pathogenic SIV variants
passaged in macaques were used, the infection was rapidly
controlled, quite unlike the persistent high-level replication
seen in natural infections (Kaur et al., 1998). Subsequent infec-
tion studies have used plasma samples harvested from SIV-in-
fected sooty mangabeys (Mandl et al., 2008). In other instances,
whether experimental infections of reservoir hosts recapitulate
features of natural infection in the wild remains to be validated.
Infections of bats with Nipah and Hendra viruses resulted in
very few bats with detectable levels of viral replication, although
in some instances seroconversion was seen nonetheless, and it
is unclear whether this very low infection level mimics infections
in the wild (Halpin et al., 2011; Middleton et al., 2007). Experi-
mental rabies infections of bat reservoir hosts led to muscle
weakness, paralysis, and reductions in body weight and were
usually lethal (Turmelle et al., 2010), but it is difficult to extrapo-
late such studies to an understanding of the mortality rate of
rabies in wild bat populations. In fact, epidemiological models
of data gathered in field studies suggest that lethality upon rabies
infection may be a far rarer outcome in wild bat populations than
in the lab (Blackwood et al., 2013). Similarly, whereas LCMV
infection of inbred mouse strains is one of the best-studied sys-
tems for viral immunity, surprisingly little is known about the
immunologic and virologic characteristics of the host-virus inter-
face in wild mouse species that are reservoir hosts for LCMV and
other arenaviruses (Table 1) (Wade et al., 2002). Host genetic dif-
ferences or small changes in the LCMV viral sequence can affect
whether infections are chronic or acute (Ahmed et al., 1988). In
addition, vertical transmission can lead to the establishment of
a life-long viral carrier state with little adaptive immune re-
sponses raised. The dependence on the host-pathogen balance
established on both strain and route of infection means that,
without much information on this, it is currently difficult to extrap-
olate insights from laboratory experiments to infections of mice
in the wild.
Notably, developing an infection model that recapitulates hu-
man disease and can be used to study host responses during
pathogenic infections to perform comparative studies with natu-
ral hosts can also be challenging if laboratory mice are not sus-
ceptible to infection or are resistant to disease. In the former
case, identification of the viral host cell receptor in humans can
enable the development of mouse strains expressing this human
protein on relevant cell types, thus enabling viral replication in
mice. For instance, the expression of human dipeptidyl pepti-
dase 4, the host cell receptor used by MERS coronovirus, in
mice using adenovirus vector-mediated transduction success-
fully rendered mice susceptible to infection with MERS corona-
virus (Zhao et al., 2014). In the case in which mice are permissive
for infection but distinct host responses lead to only mild dis-
ease, the genetic traits contributing to disease susceptibility
differences can be explored using a set of well-defined recombi-
nant inbred mouse strains, the Collaborative Cross (Churchill30 Cell 160, January 15, 2015 ª2015 Elsevier Inc.et al., 2004), as was recently done for Ebola virus infection (Ras-
mussen et al., 2014).
Investigating reservoir host immunity has also been hampered
by the paucity of available immunological tools. This includes se-
quences of immunologically important genes, markers for cell
populations of interest, and available monoclonal antibodies
specific for suchmarkers, as well as antibody tools to identify cy-
tokines or chemokines produced by immune cell populations
in vitro or in vivo. The development of such tools will be essential
to increasing the kinds of questions that can be answered.
Despite the difficulties that remain, recent methodological ad-
vances have enormous potential in their application to studies
of immune responses of natural hosts and have opened new av-
enues of research.
First, there has been a rapid expansion in genomes sequenced
for different reservoir host species. These sequences are them-
selves already informative. For instance, they allow insight into
the presence or absence of specific innate receptors or cytokine
mediators and provide clues as to the mechanism of B or T cell
repertoire diversity generation and B cell isotypes present.
Furthermore, comparative analyses can highlight genomic re-
gions with changes of possible relevance to disease outcome
upon infection and can generate hypotheses that can be tested
further. A comparison between the Pteropus alecto and Myotis
davidii bat genomes showed that several innate immune genes,
including TLR7, were under positive selection in bat ancestors
and that both species lack NK cell receptors for MHC-I, KLRs,
andKIRs (Zhang et al., 2013). Genomic approaches complement
the targeted sequencing of specific genes hypothesized to play a
role in viral control and determination of their tissue distribu-
tion—for instance, the sequencing of specific cytokine genes
in deer mice (P. maniculatus) reservoirs of hantavirus (Herbst
et al., 2002) or interferon system genes and innate receptors in
bat species (Baker et al., 2013). In addition, next-generation
sequencing is rapidly emerging as a way to define the viruses
that we may have to worry about as future emerging infections
(Mokili et al., 2012) and when comparing the baseline micro-
biome or virome of different species, as well as documenting
infection-related changes in their composition (Handley et al.,
2012; Virgin, 2014).
Second, unbiased approaches can be used to probe both
quantitative and qualitative changes in the transcriptome or
proteome. The availability of reservoir host genomes or related
species makes the use of microarray technology for gene
expression profiling possible. Furthermore, even in the absence
of a reference genome, next generation sequencing and the de
novo assembly of transcripts, while computationally more chal-
lenging, now allows the assessment of gene expression. Such
methods provide a promising means by which to illuminate
gene expression changes—for instance, in infected versus unin-
fected reservoir hosts—and to allow comparisons with changes
seen in infected humans. This approach has already been suc-
cessfully applied to characterize responses of non-natural hosts
to a number of pathogens, including infection with influenza A,
SARS, and HIV (Cameron et al., 2008; Kash et al., 2006; Moir
et al., 2011). Although such methods applied to bulk tissue sam-
ples may not be able to distinguish between the induction of
genes from changes in cell distribution, theymay identify specific
targets for further study. Eventually, the development of single-
cell transcriptome analyses and computational tools to infer
the presence of specific cell populations and their phenotype
within bulk samples may provide additional insight when flow
cytometric identification of immune cell populations usingmono-
clonal antibodies is not possible.
Lastly, our increased understanding of the various innate
immune receptors and the distinct components of pathogens
that they recognize has resulted in the availability of tools with
which to probe responses to specific receptor agonists in vivo
and in vitro. Our knowledge of innate immunity enables us to
make reasonable guesses as to which types of innate receptors
might be relevant to the host-pathogen interface of particular
viruses. This is particularly useful when the pathogen in question
requires biosafety level 4 laboratories, thus making direct infec-
tion studies challenging. Together with the methods outlined
above, it is now possible to determine which genes change
their expression early on in response to the administration of,
for instance, defined TLR agonists targeting the specific TLRs
involved in innate recognition of the virus of interest. We can
characterize specific gene circuits and their temporal regulation,
comparing responses to what is seen in more well-studied spe-
cies in that regard. It is also possible to measure differences in
basal gene expression levels, as well as quantitative changes
in response to different doses of relevant stimuli to obtain mea-
sures of the dynamic range of the response, the dose at which a
response is initiated, and its duration. In addition, innate immu-
nity can be probed in cross-sectional studies of animals, which
can provide information on how infection itself can modulate im-
mune responsiveness.
Conclusions
Given the threats to human health and economic development
posed by emerging viral diseases, better understanding the na-
ture and diversity of mechanisms responsible for the ability of
reservoir hosts to tolerate viral infections and facilitate transmis-
sion to other host species is critical. Studies to date have
focused primarily on viral detection and diversity, rather than
on illuminating the nature of the host-virus equilibrium extant in
their wild animal reservoirs. Achieving the goal of a holistic
approach to understanding viral emergence will require the inte-
gration of immunological studies with investigations of animal
physiology and metabolism, as well as the synthesis of such
studies with epidemiological, ecological, and evolutionary in-
sights of viral emergence. Cross-disciplinary collaborations
between mechanism-targeted immunology and microbiology
laboratories, veterinarians with experience in establishing col-
onies of wild species, and ecologists able to perform in-country
field studies will be especially important in advancing our knowl-
edge in this field. The enormous value of cross-geographical and
interdisciplinary initiatives in understanding viral emergence has
already been demonstrated by programs such as PREDICT, es-
tablished by the U.S. Agency for International Development to
detect emerging pandemic threats in partnership with local gov-
ernments and scientists (Morse et al., 2012). It is also apparent in
other cross-continental research teams’ efforts, such as the
multinational collaboration that promptly tracked the emergence
and evolution of the Ebola virus variants responsible for theongoing outbreak in West Africa (Gire et al., 2014). The develop-
ment of immunological reagents, in addition to the application of
recently developed methods to define host genome sequences
and to characterize patterns of host gene expression following
infection or other experimental intervention, will yield valuable
insights into immune responses elicited by emerging viruses in
their natural hosts. Such studies may identify important path-
ways of pathogenesis in humans by elucidating why these infec-
tions result in such distinct infection outcomes in natural hosts
and may indicate novel approaches for the treatment and pre-
vention of zoonotic infections. They may also establish whether
there are fundamental immunologic reasons—in addition to pro-
posed behavioral, ecological, and evolutionary ones—to explain
why certain animals, including bats, primates, and rodents, are
most often implicated as the reservoir hosts for emerging viral
zoonoses. Finally, studies of reservoir hosts stand to significantly
advance our understanding of fundamental immunological pro-
cesses contributing to host resistance and disease tolerance.
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